Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease-part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up

Spine

Volumn 38, Issue 13, 2013, Pages 1128-1136

  Crandall, Dennis G ^a,b,c   Revella, Jan ^b   Patterson, Jason ^c   Huish, Eric ^b   Chang, Michael ^a,b,c   McLemore, Ryan ^c  

^a Sonoran Spine Center   (United States)

^b Sonoran Spine Research and Education Foundation   (United States)

^c Banner Good Samaritan Orthopaedic Residency Program   (United States)

Author keywords

BMP; Scoliosis; Spinal deformity; Spinal fusion outcomes; Spondylolisthesis; Transforaminal lumbar interbody fusion (TLIF)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEGENERATIVE DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDICLE SCREW; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SCORING SYSTEM; SPINE MALFORMATION; SPINE SURGERY; SPONDYLOLISTHESIS; TRANSFORAMINAL LUMBAR INTERBODY FUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 2; BONE SCREWS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVERTEBRAL DISC DEGENERATION; LOGISTIC MODELS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPINAL DISEASES; SPINAL FUSION; SPONDYLOLISTHESIS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879113582     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31828864e6     Document Type: Article

References (31)

1. Hackenberg L, Halm H, Bullmann V, et al. Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results. Eur Spine J 2005; 14: 551-8.
2. Ploumis A, Wu C, Fischer G, et al. Biomechanical comparison of anterior lumbar interbody fusion and transforaminal lumbar interbody fusion. J Spinal Disord Tech 2008; 21: 120-5.
3. Hsieh P, Koski T, O'Shaughnessy B, et al. Anterior lumbar interbody fusion in comparison with transforaminal lumbar interbody fusion: implications for the restoration of foraminal height, local disc angle, lumbar lordosis, and sagittal balance. J Neurosurg Spine 2007; 7: 379-86.
4. Niemeyer T, Koriller M, Claes L, et al. In vitro study of biomechanical behavior of anterior and transforaminal lumbar interbody instrumentation techniques. Neurosurgery 2006; 59: 1271-6.
5. Crandall D, Huish E, Revella J, et al. Low-grade spondylolisthesis reduction and TLIF with rhBMP-2: technique, complications, and 4 year outcomes. International Meeting on Advanced Spine Techniques, 2010.
6. McAffee P, DeVine J, Chaput C, et al. The indications for interbody fusion cages in the treatment of spondylolisthesis: analysis of 120 cases. Spine 2005; 30: S60-5.
7. Crandall D, Revella J. Transforaminal lumbar interbody fusion versus anterior lumbar interbody fusion as an adjunct to posterior instrumented correction of degenerative lumbar scoliosis: three year clinical and radiographic outcomes. Spine 2009; 34: 2126-33.
8. Ito Z, Matsuyama Y, Sakai Y, et al. Bone union rate with autologous iliac bone versus local bone graft in posterior lumbar interbody fusion. Spine 2010; 35: E1101-5.
9. Potter B, Freedman B, Verwiebe E, et al. Transforaminal lumbar interbody fusion: clinical and radiographic results and complications in 100 consecutive patients. J Spinal Disord Tech 2005; 18: 337-46.
10. Park P, Foley K. Minimally invasive transforaminal lumbar interbody fusion with reduction of spondylolisthesis: technique and outcomes after a minimum of 2 years follow-up. Neurosurg Focus 2008;25:E16.
11. Anand N, Hamilton JF, Perri B, et al. Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome. Spine 2006; 31: E748-53.
12. Rihn JA, Patel R, Makda J, et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 2009; 9: 623-9.
13. Crandall D, Revella J, Patterson J, et al. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity and degenerative disease-Part 2: BMP dosage related complications and longterm outcomes in 509 patients. Spine 2013; 38: 1137-45.
14. Cutler A, Siddiqui S, Mohan A, et al. Comparison of polyetheretherketone cages with femoral cortical bone allograft as a single piece interbody spacer in transforaminal lumbar interbody fusion. J Neurosurg Spine 2006; 5: 534-9.
15. Joseph V, Rampersaud Y. Heterotopic bone formation with the use of rhBMP-2 in posterior minimal access interbody fusion: a CT analysis. Spine 2007; 32: 2885-90.
16. Mummaneni P, Pan J, Haid R, et al. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. J Neurosurg (Spine 1) 2004; 1: 19-23.
17. Lowe T, Tahernia A, Obrien M, et al. Unilateral transforaminal posterior lumbar interbody fusion (TLIF): indications, technique, and 2 year results. J Spinal Dis Tech 2002; 15: 31-8.
18. Mura PP, Costaglioli M, Piredda M, et al. TLIF for symptomatic disc degeneration: a retrospective study of 100 patients. Eur Spine J 2011; 1: S57-60.
19. Villavicencia A, Burneikiene S, Bulsara K, et al. Perioperative complications in transforaminal lumbar interbody fusion versus anterior-posterior reconstruction for lumbar disc degeneration and instability. J Spinal Dis Tech 2006; 19: 92-97.
20. Schwender J, Holly L, Rouben D, et al. Minimally invasive transforaminal lumbar interbody fusion (TLIF): Technical feasibility and initial results. J Spinal Dis Tech 2005; 18: S1-6.
21. Okuda S, Miyauchi A, Oda T, et al. Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine 2006; 4: 304-9.
22. Okuyama K, Abe E, Suzuki T, et al. Posterior lumbar interbody fusion: a retrospective study of complications after facet joint excision and pedicle screw fixation in 148 cases. Acta Orthop Scand 1999; 70: 329-34.
23. Ong K, Villarraga M, Lau E, et al. Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine 2010; 35: 1794-800.
24. Owens K, Glassman SD, Howard JM, et al. Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion. Eur Spine J 2011; 20: 612-7.
25. Meisel H, Schnoring M, Hohaus C, et al. Posterior lumbar interbody fusion using rhBMP-2. Eur Spine J 2008; 17: 1735-44.
26. Geibel PT, Boyd DL, Slabisak V. The use of recombinant human bone morphogenic protein in posterior interbody fusions of the lumbar spine. J Spine Dis Tech 2009; 22: 315-20.
27. Selznick LA, Shamji MF, Isaacs RE. Minimally invasive interbody fusion for revision lumbar surgery: technical feasibility and safety. J Spinal Disord Tech 2009; 22: 207-13.
28. Wang J, Zhou Y, Zhang ZF, et al. Minimally invasive or open transforaminal lumbar interbody fusion as revision surgery for patients previously treated by open discectomy and decompression of the lumbar spine. Eur Spine J 2011; 20: 623-8.
29. Rose PS, Lenke LG, Bridwell KH, et al. Pedicle screw instrumentation for adult idiopathic scoliosis: an improvement over hook/hybrid fixation. Spine 2009; 34: 852-7; discussion 858.
30. Li F, Chen Q, Chen W, et al. Posterior-only approach with selective segmental TLIF for degenerative lumbar scoliosis. J Spinal Disord Tech 2011; 24: 308-12.
31. Burneikiene S, Nelson EL, Mason A, et al. Complications in patients undergoing combined transforaminal lumbar interbody fusion and posterior instrumentation with deformity correction for degenerative scoliosis and spinal stenosis. Surg Neurol Int 2012; 3: 25.